dyslipidemia
2,3,7,8-tetrachlorodibenzo-?-dioxin (TCDD) induces hepatic dyslipidemia mediated by the aryl hydrocarbon receptor (AhR).
2,3,7,8-tetrachlorodibenzo-?-dioxin (TCDD) induces hepatic <span class="disease" id="21890736-1-59-71">dyslipidemia</span> mediated by the <span class="gene" id="21890736-1-88-113">aryl hydrocarbon receptor</span> (<span class="gene" id="21890736-1-115-118">AhR</span>).